home / stock / chma / chma news


CHMA News and Press, Chiasma Inc.

Stock Information

Company Name: Chiasma Inc.
Stock Symbol: CHMA
Market: NASDAQ
Website: chiasmapharma.com

Menu

CHMA CHMA Quote CHMA Short CHMA News CHMA Articles CHMA Message Board
Get CHMA Alerts

News, Short Squeeze, Breakout and More Instantly...

CHMA - Merger Arbitrage Mondays - Veoneer Receives A Superior Bid From Qualcomm

Six multi-billion dollar deals announced last week. VICI Properties acquires MGM Growth Properties for $17.2 billion. Veoneer receives a superior bid from Qualcomm. For further details see: Merger Arbitrage Mondays - Veoneer Receives A Superior Bid From Qualcomm

CHMA - Merger Arbitrage Mondays - Thoma Bravo Announces 2 Large Deals In A Single Month

19 new deals announced in the month of July. Thoma Bravo acquires Medallia. Aon and Willis Towers Watson terminated their business combination agreement. For further details see: Merger Arbitrage Mondays - Thoma Bravo Announces 2 Large Deals In A Single Month ...

CHMA - Pulmatrix appoints Director Anand Varadan

Pulmatrix appoints Director Anand Varadan PR Newswire LEXINGTON, Mass. , July 27, 2021 /PRNewswire/ -- Pulmatrix, Inc. (NASDAQ: PULM), a clinical-stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary and...

CHMA - Merger Arbitrage Mondays - Thoma Bravo Acquires Stamps.com At A Huge Premium

Welbilt receives a second more lucrative offer from the Ali Group that is well above the current all-stock deal with Middleby. Regulatory agencies flex their muscles with China’s antitrust regulator blocking Tencent Holdings’ plan to merge Huya and DouYu. EU approves...

CHMA - Merger Arbitrage Mondays - MKS Instruments' Rumored Deal With Atotech Materializes

Over 70 multi-billion dollar deals announced in the first half of the year. SPAC IPOs pick up pace and Chamath Palihapitiya files four new biotech focused SPACs. Icon completes the acquisition of PRA Health Sciences. For further details see: Merger Arbitrage Mondays - MK...

CHMA - Chiasma Announces Submission of Marketing Authorization Application for MYCAPSSA® to the European Medicines Agency

NEEDHAM, Mass., June 28, 2021 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ: CHMA), (“Chiasma” or the “Company”), a commercial-stage biopharmaceutical company utilizing its delivery platform technology to develop and commercialize oral therapies to improve the lives ...

CHMA - Merger Arbitrage Mondays - Magnachip Receives A Rival Bid

Nearly $13 billion worth of all cash deals announced last week. Magnachip receives a higher bid, but trades well below the original acquisition price due to regulatory risks. SPAC activity picks up with 9 new IPOs filed. For further details see: Merger Arbitrage Mondays ...

CHMA - Merger Arbitrage Mondays: Extended Stay America Receives A Bump

Regional bank consolidation continues with three new bank deals announced last week. Extended Stay America catches a higher bid. Chamath Palihapitiya files for four new biotech-focused SPACs. For further details see: Merger Arbitrage Mondays: Extended Stay America Receiv...

CHMA - Merger Arbitrage Mondays - Italy's Ali Group Bids $3.3 Billion For Welbilt

Ali Group ignites a potential bidding war for Welbilt (WBT). Cimarex Energy (XEC) and Cabot Oil & Gas Corporation (COG) combine in an $8.5 billion all-stock deal. United Rentals (UFN) completes the acquisition of General Finance Corporation (GFN) in 40 days. For further ...

CHMA - Chiasma posts positive data from late-stage MYCAPSSA study

Chiasma (CHMA) presented patient-reported outcomes ((PROs)) data from its late-stage trial in which patients with acromegaly reported significantly improved quality of life and work productivity after transitioning to the company's MYCAPSSA treatment.The patients showed improvements when tran...

Next 10